2015-22626. Manufacturer of Controlled Substances Registration: PCAS-Nanosyn, LLC  

  • Start Preamble

    ACTION:

    Notice of registration.

    SUMMARY:

    PCAS-Nanosyn, LLC applied to be registered as a manufacturer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants PCAS-Nanosyn, LLC registration as a manufacturer of those controlled substances.

    End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    By notice dated May 15, 2015, and published in the Federal Register on May 21, 2015, 80 FR 29336, PCAS-Nanosyn, LLC, 3331-B Industrial Drive, Santa Rosa, California 95403 applied to be registered as a manufacturer of certain basic classes of controlled substances. No comments or objections were submitted for this notice.

    The DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of PCAS-Nanosyn, LLC to manufacture the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company's maintenance of effective controls against diversion by inspecting and testing the company's physical security systems, verifying the company's compliance with state and local laws, and reviewing the company's background and history.

    Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above-named company is granted registration as a bulk manufacturer of the basic classes of controlled substances:

    Controlled substanceSchedule
    Oxycodone (9143)II
    Oripavine (9330)II
    Oxymorphone (9652)II
    Fentanyl (9801)II

    The company is a contract manufacturer. At the request of the company's customers, it manufacturers Start Printed Page 54328derivatives of controlled substances in bulk form.

    Start Signature

    Dated: September 1, 2015

    Joseph T. Rannazzisi,

    Deputy Assistant Administrator.

    End Signature End Supplemental Information

    [FR Doc. 2015-22626 Filed 9-8-15; 8:45 am]

    BILLING CODE 4410-09-P

Document Information

Published:
09/09/2015
Department:
Drug Enforcement Administration
Entry Type:
Notice
Action:
Notice of registration.
Document Number:
2015-22626
Pages:
54327-54328 (2 pages)
Docket Numbers:
Docket No. DEA-392
PDF File:
2015-22626.pdf